Mesangial C4d Deposits in Early IgA Nephropathy
- PMID: 29146701
- PMCID: PMC5967419
- DOI: 10.2215/CJN.02530317
Mesangial C4d Deposits in Early IgA Nephropathy
Abstract
Background and objectives: The prognostic value of mesangial C4d deposits in IgA nephropathy has been analyzed in patients with reduced GFR but has not been analyzed in those with normal kidney function. The main objective of the study was to analyze the prognostic value of C4d deposits and association with response to treatment in patients with IgA nephropathy and normal GFR.
Design, setting, participants, & measurements: This retrospective cohort study included 190 patients with idiopathic IgA nephropathy diagnosed by kidney biopsy between 1988 and 2005. The patients had GFR≥80 ml/min per 1.73 m2 at the time of diagnosis, and they had a paraffin-embedded kidney biopsy with eight glomeruli available.
Results: In total, 170 (89%) and 20 (11%) patients were >18 and <18 years old, respectively; median (interquartile range) follow-up was 15 (12-22) years. Mesangial C4d deposit prevalence was 20% (38 of 190). At diagnosis, C4d-positive versus -negative patients had higher protein-to-creatinine ratio (median [interquartile range]: 1.94 g/g [0.9-3.1] versus 1.45 g/g [0.9-2.2]; P=0.04). During follow-up, C4d-positive patients showed a higher number of nephritic flares (median [range]: 1.4 [0-5] versus 0.9 [0-2]; P=0.04), had a higher protein-to-creatinine ratio (median [interquartile range]: 1.32 g/g [0.7-1.7] versus 0.89 g/g [0.1-1.3]; P<0.01), were more prone to receive repeated treatment with corticosteroids (45% versus 24%; P<0.01), and showed a larger reduction in eGFR (-1.6 versus -0.8 ml/min per 1.73 m2 per year; P=0.04). Furthermore, the presence of mesangial C4d deposits was an independent predictor of long-term kidney survival.
Conclusions: C4d deposits may be one of the earliest poor prognostic variables available for patients with idiopathic IgA nephropathy and normal kidney function at the time of diagnosis. However, Cd4 deposits alone are not associated with the response to angiotensin blockers or corticosteroid treatment.
Keywords: Adrenal Cortex Hormones; Biopsy; C4d deposits; Follow-Up Studies; Glomerular Mesangium; Glomerulonephritis, IGA; Humans; IgA nephropathy; Kidney Glomerulus; Paraffin; Prevalence; Renal Insufficiency, Chronic; Retrospective Studies; complement activation; creatinine; glomerular filtration rate; kidney; lectin-pathway; prognosis.
Copyright © 2018 by the American Society of Nephrology.
Similar articles
-
Mesangial C4d deposition may predict progression of kidney disease in pediatric patients with IgA nephropathy.Pediatr Nephrol. 2017 Jul;32(7):1211-1220. doi: 10.1007/s00467-017-3610-y. Epub 2017 Feb 23. Pediatr Nephrol. 2017. PMID: 28233100
-
Mesangial C4d deposition: a new prognostic factor in IgA nephropathy.Nephrol Dial Transplant. 2009 Mar;24(3):886-91. doi: 10.1093/ndt/gfn563. Epub 2008 Oct 8. Nephrol Dial Transplant. 2009. PMID: 18842673
-
Association of C4d deposition with clinical outcomes in IgA nephropathy.Clin J Am Soc Nephrol. 2014 May;9(5):897-904. doi: 10.2215/CJN.09710913. Epub 2014 Feb 27. Clin J Am Soc Nephrol. 2014. PMID: 24578331 Free PMC article.
-
Immunoglobulin a nephropathy: Pathological markers of renal survival in paediatric patients.Nephrology (Carlton). 2016 Dec;21(12):995-1002. doi: 10.1111/nep.12850. Nephrology (Carlton). 2016. PMID: 27414046 Review.
-
Role of complement in IgA nephropathy.J Nephrol. 2016 Feb;29(1):1-4. doi: 10.1007/s40620-015-0245-6. Epub 2015 Nov 13. J Nephrol. 2016. PMID: 26567162 Free PMC article. Review.
Cited by
-
Systematic Review of the Link Between Oxford MEST-C Classification and Complement Activation in IgA Nephropathy.Kidney Int Rep. 2023 Nov 14;9(2):356-369. doi: 10.1016/j.ekir.2023.11.005. eCollection 2024 Feb. Kidney Int Rep. 2023. PMID: 38344730 Free PMC article.
-
Evaluating Progression Risk in Patients With Immunoglobulin A Nephropathy.Kidney Int Rep. 2023 Sep 22;8(12):2515-2528. doi: 10.1016/j.ekir.2023.09.020. eCollection 2023 Dec. Kidney Int Rep. 2023. PMID: 38106572 Free PMC article. Review.
-
Targeting complement in IgA nephropathy.Clin Kidney J. 2023 Dec 4;16(Suppl 2):ii28-ii39. doi: 10.1093/ckj/sfad198. eCollection 2023 Dec. Clin Kidney J. 2023. PMID: 38053977 Free PMC article. Review.
-
IgA nephropathy.Nat Rev Dis Primers. 2023 Nov 30;9(1):67. doi: 10.1038/s41572-023-00476-9. Nat Rev Dis Primers. 2023. PMID: 38036542 Review.
-
Challenges in IgA Nephropathy Management: An Era of Complement Inhibition.Kidney Int Rep. 2023 Jun 21;8(9):1730-1740. doi: 10.1016/j.ekir.2023.06.010. eCollection 2023 Sep. Kidney Int Rep. 2023. PMID: 37705895 Free PMC article. Review.
References
-
- Coppo R, D’Amico G: Factors predicting progression of IgA nephropathies. J Nephrol 18: 503–512, 2005 - PubMed
-
- Gutiérrez E, Zamora I, Ballarín JA, Arce Y, Jiménez S, Quereda C, Olea T, Martínez-Ara J, Segarra A, Bernis C, García A, Goicoechea M, García de Vinuesa S, Rojas-Rivera J, Praga M; Grupo de Estudio de Enfermedades Glomerulares de la Sociedad Española de Nefrología (GLOSEN) : Long-term outcomes of IgA nephropathy presenting with minimal or no proteinuria. J Am Soc Nephrol 23: 1753–1760, 2012 - PMC - PubMed
-
- Bartosik LP, Lajoie G, Sugar L, Cattran DC: Predicting progression in IgA nephropathy. Am J Kidney Dis 38: 728–735, 2001 - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
Miscellaneous
